HKD 20.5
(-3.76%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 8.04 Million USD | -39.69% |
2022 | 13.34 Million USD | 38.8% |
2021 | 9.61 Million USD | -28.22% |
2020 | 13.39 Million USD | 22.0% |
2019 | 10.97 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 7.54 Million USD | 0.0% |
2024 Q2 | 5.8 Million USD | 0.0% |
2023 Q2 | 11.75 Million USD | -9.43% |
2023 FY | 8.04 Million USD | -39.69% |
2023 Q4 | 8.04 Million USD | -17.95% |
2023 Q3 | 9.8 Million USD | -16.56% |
2023 Q1 | 12.97 Million USD | -2.73% |
2022 Q1 | 11.09 Million USD | 15.46% |
2022 FY | 13.34 Million USD | 38.8% |
2022 Q4 | 13.34 Million USD | -3.95% |
2022 Q3 | 13.89 Million USD | 7.19% |
2022 Q2 | 12.96 Million USD | 16.77% |
2021 Q1 | 12.3 Million USD | -8.1% |
2021 Q2 | 11.96 Million USD | -2.75% |
2021 Q3 | 10.65 Million USD | -11.0% |
2021 Q4 | 9.61 Million USD | -9.75% |
2021 FY | 9.61 Million USD | -28.22% |
2020 Q4 | 13.39 Million USD | 0.0% |
2020 Q2 | 10.45 Million USD | 0.0% |
2020 Q1 | - USD | -100.0% |
2020 FY | 13.39 Million USD | 22.0% |
2019 Q3 | 10.7 Million USD | 130.34% |
2019 Q4 | 10.97 Million USD | 2.56% |
2019 Q2 | 4.64 Million USD | 0.0% |
2019 FY | 10.97 Million USD | 0.0% |
2019 Q1 | 4.64 Million USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2015 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 30.61 Million HKD | 73.713% |
CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 99.812% |